These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31839824)

  • 1. Role of Adjuvant Chemotherapy in Advanced Stage Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: Competing Risk Analysis after Propensity Score-Matching.
    Kang M; Yoo H; Kim K; Sung SH; Jeon HG; Park SH; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
    J Cancer; 2019; 10(27):6896-6902. PubMed ID: 31839824
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
    Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
    Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
    BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis.
    Lo CW; Li WM; Ke HL; Chang YH; Wu HC; Chen IA; Lin JT; Huang CY; Chen CH; Tseng JS; Lin WR; Jiang YH; Lee YK; Tsai CY; Chung SD; Hsueh TY; Chiu AW; Jou YC; Cheong IS; Chen YT; Chen JS; Chiang BJ; Yu CC; Lin WY; Wu CC; Chen CS; Weng HY; Tsai YC
    Front Oncol; 2022; 12():843715. PubMed ID: 35530335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Adjuvant Chemotherapy on Locally Advanced Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis.
    Kim DK; Kim JW; Jung HD; Ahn HK; Lee JY; Cho KS
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1193-e1202. PubMed ID: 31543442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical Recurrence After Radical Nephroureterectomy of Upper Urinary Tract Urothelial Carcinoma: A Large Population-Based Investigation of Clinicopathologic Characteristics and Survival Outcomes.
    Wu J; Xu PH; Luo WJ; Dai B; Shen YJ; Ye DW; Wang YC; Zhu YP
    Front Surg; 2021; 8():590448. PubMed ID: 33693025
    [No Abstract]   [Full Text] [Related]  

  • 10. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.
    Raman JD; Lin YK; Kaag M; Atkinson T; Crispen P; Wille M; Smith N; Hockenberry M; Guzzo T; Peyronnet B; Bensalah K; Simhan J; Kutikov A; Cha E; Herman M; Scherr D; Shariat SF; Boorjian SA
    Urol Oncol; 2014 Jan; 32(1):47.e9-14. PubMed ID: 24140248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
    Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
    BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis.
    Moschini M; Zamboni S; Afferi L; Pradere B; Abufaraj M; Soria F; D'Andrea D; Roupret M; De la Taille A; Simeone C; Mattei A; Mathieu R; Bensalah K; Wirth MP; Montorsi F; Briganti A; Gallina A; Simone G; Gallucci M; Di Bona C; Marra G; Mari A; Di Trapani E; Alvarez Maestro M; Krajewski W; Shariat SF; Xylinas E; Baumeister P
    Arab J Urol; 2020 Sep; 19(1):31-36. PubMed ID: 33763246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Seisen T; Krasnow RE; Bellmunt J; Rouprêt M; Leow JJ; Lipsitz SR; Vetterlein MW; Preston MA; Hanna N; Kibel AS; Sun M; Choueiri TK; Trinh QD; Chang SL
    J Clin Oncol; 2017 Mar; 35(8):852-860. PubMed ID: 28045620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of stage II-IV upper-tract urothelial carcinoma and adjuvant chemotherapy for locally advanced cancer.
    Chang YH; Hsiao PJ; Chen GH; Lin CC; Chang CH; Wu HC; Huang CP; Yang CR; Yeh SP
    Oncol Lett; 2019 Jan; 17(1):1341-1348. PubMed ID: 30655904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective controlled observation ofeffect of adjuvant chemotherapy onsurvival and prognosis ofhigh-risk upper tract urothelial carcinoma patients underwent radical nephroureterectomy].
    Luo Y; Feng BF; Wei DC; Han YL; Li MC; Zhao JH; Lin YH; Li Q; Hou Z; Zhang GY; Jiang YG
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3158-3163. PubMed ID: 31694107
    [No Abstract]   [Full Text] [Related]  

  • 16. Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.
    Sevillano E; Werner L; Bossé D; Lalani AA; Wankowicz SAM; de Velasco G; Farina M; Lundgren K; Choueiri TK; González Del Alba A; Bellmunt J
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1089-e1094. PubMed ID: 28864222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.
    Lucca I; Kassouf W; Kapoor A; Fairey A; Rendon RA; Izawa JI; Black PC; Fajkovic H; Seitz C; Remzi M; Nyirády P; Rouprêt M; Margulis V; Lotan Y; de Martino M; Hofbauer SL; Karakiewicz PI; Briganti A; Novara G; Shariat SF; Klatte T
    BJU Int; 2015 Jul; 116(1):72-8. PubMed ID: 24825476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical recurrence factors and outcome after radical nephroureterectomy for upper tract urothelial carcinoma: Multivariate analysis with propensity score matching.
    Zhao H; Jiao B; Liu K; Luo Z; Ding Z; Lai S; Ren J; Zhang G
    Front Oncol; 2022; 12():984014. PubMed ID: 36059684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Adjuvant Gemcitabine Containing Chemotherapy Following Radical Nephroureterectomy for Patients with Upper Tract Urothelial Carcinoma: Results from a Propensity-Score Matched Cohort Study.
    Hongda Z; Kang L; Ng CF; de la Rosette J; Laguna P; Gontero P; Baard J; Yildiz O; Teoh JY
    Bladder Cancer; 2023; 9(3):217-226. PubMed ID: 38993186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.